Ovaleap 300 IU/0.5 ml
Ovaleap 300 IU/0.5 ml is a medicine authorised by Swissmedic under authorisation number 66255. The authorisation holder is Labatec Pharma SA. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 28 August 2018 and the authorisation is valid without a time limit. ATC code G03GA05 places the medicine in the group Sex hormones and modulators of the genital system.
| Authorisation number | 66255 |
|---|---|
| Name | Ovaleap 300 IU/0.5 ml |
| Full name | Ovaleap 300 IU/0.5 ml, solution injectable |
| Authorisation holder | Labatec Pharma SA |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | G03GA05 |
| First authorisation | 28 August 2018 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Ovaleap 300 IU/0.5 ml, solution injectable | A | 28 August 2018 |
| 2 | Ovaleap 450 IU/0.75 ml, solution injectable | A | 28 August 2018 |
| 3 | Ovaleap 900 IU/1.5 ml, solution injectable | A | 28 August 2018 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 cartouche avec 10 aiguilles d'injection | G03GA05 | 07.08.1. | A | |
| 2 | 1 cartouche avec 10 aiguilles d'injection | G03GA05 | 07.08.1. | A | |
| 3 | 1 cartouche avec 20 aiguilles d'injection | G03GA05 | 07.08.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Ovaleap 300 IU/0.5 ml authorised in Switzerland?
Yes. Ovaleap 300 IU/0.5 ml is authorised by Swissmedic under authorisation number 66255, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Ovaleap 300 IU/0.5 ml have?
Ovaleap 300 IU/0.5 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Ovaleap 300 IU/0.5 ml?
The authorisation holder is Labatec Pharma SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.